Revolution Medicines' GAAP loss for 6M 2021 was $81.475 million, up 74.3% from $46.734 million in the previous year. Revenue decreased 12.7% to $18.829 million from $21.571 million a year earlier.
Revolution Medicines' GAAP loss for 6M 2021 was $81.475 million, up 74.3% from $46.734 million in the previous year. Revenue decreased 12.7% to $18.829 million from $21.571 million a year earlier. 
ir.revmed.com
English (US) 